LEVERAGER
Live / Applied — Fifth extension granted (statement of use) (as of 16 Jan 2026)
What this means for you
Not registered yet, but its 27 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97432416
- Mark type
- Stylized text
- Filed
- 27 May 2022
- Published for opposition
- 21 Feb 2023
- Attorney of record
- Perry Gattegno
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; Research and development in the field of design of RNA-targeted drugs
Owner
- Fosun Pharma USA Inc., Princeton, NJ, US
- Fosun Pharma USA Inc., Princeton, NJ, US
Prosecution history
- 17 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jan 2026 — SOU EXTENSION 5 GRANTED
- 27 Aug 2025 — SOU EXTENSION 5 FILED
- 16 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 4 GRANTED
- 26 Mar 2025 — SOU EXTENSION 4 FILED
- 26 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2024 — SOU EXTENSION 3 GRANTED
- 15 Oct 2024 — SOU EXTENSION 3 FILED
- 15 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 07 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Feb 2024 — SOU EXTENSION 2 GRANTED